Shared Genetic Contributions to Atrial Fibrillation and Ischemic Stroke Risk

Atrial fibrillation is a prevalent arrhythmia associated with a five-fold increased risk of ischemic stroke, and specifically the cardioembolic stroke subtype. Genome-wide association studies of these traits have yielded overlapping risk loci, but genome-wide investigation of genetic susceptibility shared between stroke and atrial fibrillation is lacking. Comparing the genetic architectures of the two diseases could inform whether cardioembolic strokes are driven by inherited atrial fibrillation susceptibility, and may help elucidate ischemic stroke mechanisms. Here, we analyze genome-wide genotyping data and estimate SNP-based heritability in atrial fibrillation and cardioembolic stroke to be nearly identical (20.0% and 19.5%, respectively). Further, we find that the traits are genetically correlated (r=0.77 for SNPs with p -4 in a previous atrial fibrillation meta-analysis). Clinical studies are warranted to assess whether genetic susceptibility to atrial fibrillation can be leveraged to improve the diagnosis and care of ischemic stroke patients.

[1]  K. Lunetta,et al.  Heritability of Atrial Fibrillation , 2017, Circulation. Cardiovascular genetics.

[2]  Sekar Kathiresan,et al.  Genome-wide polygenic score to identify a monogenic risk-equivalent for coronary disease , 2017, bioRxiv.

[3]  E. Vassos,et al.  Prospects for using risk scores in polygenic medicine , 2017, Genome Medicine.

[4]  K. Lunetta,et al.  Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation , 2017, Circulation.

[5]  P. Visscher,et al.  10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.

[6]  Henry J. Lin,et al.  Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation , 2017, Nature Genetics.

[7]  P. O’Reilly,et al.  An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis , 2017, Biological Psychiatry.

[8]  E. Boerwinkle,et al.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.

[9]  D. McManus,et al.  Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes , 2016, Stroke.

[10]  Jonathan P. Beauchamp,et al.  Genome-wide association study identifies 74 loci associated with educational attainment , 2016, Nature.

[11]  C. Sudlow,et al.  Low-frequency and common genetic variation in ischemic stroke , 2016, Neurology.

[12]  J. Lee,et al.  Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study , 2016, The Lancet Neurology.

[13]  J. Maguire.  NINDS Stroke Genetics Network (SiGN) and International Stroke Genetics Consortium (ISGC)., Attia, J. R., & Holliday, E. (2015) Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study. Lancet Neurology, 174-184. doi:10.1016/S1474-4422(15)00338-5 , 2016 .

[14]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[15]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[16]  Jane E. Carpenter,et al.  Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.

[17]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[18]  S. O’Brien,et al.  SmileFinder: a resampling-based approach to evaluate signatures of selection from genome-wide sets of matching allele frequency data in two or more diploid populations , 2015, GigaScience.

[19]  D. Heckerman,et al.  Further Improvements to Linear Mixed Models for Genome-Wide Association Studies , 2014, Scientific Reports.

[20]  R. Sacco,et al.  Agreement between TOAST and CCS ischemic stroke classification , 2014, Neurology.

[21]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[22]  S. Connolly,et al.  Embolic strokes of undetermined source: support for a new clinical construct–Authors' reply , 2014, The Lancet Neurology.

[23]  Ross M. Fraser,et al.  Defining the role of common variation in the genomic and biological architecture of adult human height , 2014, Nature Genetics.

[24]  B. Berger,et al.  Efficient Bayesian mixed model analysis increases association power in large cohorts , 2014, Nature Genetics.

[25]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[26]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[27]  David J Gladstone,et al.  Atrial fibrillation in patients with cryptogenic stroke. , 2014, The New England journal of medicine.

[28]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[29]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[30]  P. Visscher,et al.  Advantages and pitfalls in the application of mixed-model association methods , 2014, Nature Genetics.

[31]  David D. McManus,et al.  Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium , 2013, Journal of the American Heart Association.

[32]  C. Sudlow,et al.  Genetic Heritability of Ischemic Stroke and the Contribution of Previously Reported Candidate Gene and Genomewide Associations , 2012, Stroke.

[33]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[34]  Eleazar Eskin,et al.  Improved linear mixed models for genome-wide association studies , 2012, Nature Methods.

[35]  Martin O'Donnell,et al.  Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial , 2012, The Lancet Neurology.

[36]  Ying Liu,et al.  FaST linear mixed models for genome-wide association studies , 2011, Nature Methods.

[37]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[38]  F. Fazekas,et al.  The Causative Classification of Stroke system: An international reliability and optimization study , 2010, Neurology.

[39]  Stefan Kääb,et al.  Genetics of Atrial Fibrillation: Implications for Future Research Directions and Personalized Medicine , 2010, Circulation. Arrhythmia and electrophysiology.

[40]  C. Gieger,et al.  A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.

[41]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[42]  V. Feigin,et al.  Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review , 2009, The Lancet Neurology.

[43]  C. Gieger,et al.  Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke , 2008, Annals of neurology.

[44]  Thomas Benner,et al.  A Computerized Algorithm for Etiologic Classification of Ischemic Stroke: The Causative Classification of Stroke System , 2007, Stroke.

[45]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[46]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[47]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[48]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[49]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[50]  Olaf Gefeller,et al.  Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study , 2001, Stroke.

[51]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[52]  David B. Matchar,et al.  Improving the Reliability of Stroke Subgroup Classification Using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Criteria , 2001, Stroke.

[53]  W M O'Fallon,et al.  Ischemic stroke subtypes: a population-based study of incidence and risk factors. , 1999, Stroke.

[54]  P. Gorelick.  Cerebrovascular disease in African Americans. , 1998, Stroke.

[55]  M R Franz,et al.  Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. , 1997, Journal of the American College of Cardiology.

[56]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[57]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[58]  C. Sudlow,et al.  Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms , 2017, Stroke.

[59]  D. Croteau-Chonka,et al.  New genetic loci link adipose and insulin biology to body fat distribution , 2015 .

[60]  Pieter B. T. Neerincx,et al.  Supplementary Information Whole-genome sequence variation , population structure and demographic history of the Dutch population , 2022 .